BioForward names Renk as new executive director
BioForward, the member organization that represents the state’s biotechnology industry, has named Bryan Renk to the position of Executive Director. Hie will start the position on Oct. 1. ...
BioForward, the member organization that represents the state’s biotechnology industry, has named Bryan Renk to the position of Executive Director. Hie will start the position on Oct. 1. ...
A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells - suggesting a future in which damaged retinas could be repaired by cells grown from the...
Increasingly, indications are that the H1N1 influenza might pose a greater health threat than we saw with the recent pandemic. There are two reasons to think this. First the World Health Organization is receiving reports that Tamiflu-resistant H1N1 strains are popping up around the world. The...
The latest version of the Ernst & Young annual report on the biotechnology (and pharma) industry is chock full of good information and needs time for digestion, so much so that it might be the source of several more articles. My only complaint about this...
Prodesse today said that the US Food and Drug Administration has cleared additional claims for the firm's ProFlu+ assay, which says that the assay can detect the 2009 H1N1 influenza virus. The Milwaukee, Wis.-based firm said in a statement that reactivity testing completed by the firm...
An average of 40,000 Americans per day are given a radioactive isotope that acts as a light source within their bodies, illuminating cancerous tumors and heart problems that doctors otherwise couldn't detect - short of surgery and other procedures that are riskier, more costly and...
It's not the stuff of a town hall shouting match, but one of the most far-reaching elements of the national debate over health care is the question of how long to protect breakthrough drugs produced by biotechnology from copycat generics. One side argues that five years...
MADISON — Flex Biomedical, Inc., a privately-held orthopedics company focused on developing novel treatments and diagnostics for orthopedic diseases today announced it has raised $985,000 including a $150,000 Technology Venture Fund Loan from the state of Wisconsin. The company is moving its operations from Boston,...
Infection with the avian influenza virus might cause a predisposition to Parkinson's disease, according to research published this week in the Proceedings of the National Academy of Sciences. ...
Flex Biomedical Inc., a privately held company developing treatments and diagnostics for orthopedic diseases, said that it has raised $985,000, including a $150,000 loan from the state's Technology Venture Fund, and that it is moving its operations from Boston to Madison. Read full article>>...